Welcome to AdaptiM3D

AdaptiM3D is reducing pharmaceutical clinical trial times and costs using an innovative 3D printing technology.

As a spin-out from the University of Strathclyde, we're focused on transforming how clinical trials are conducted, working to deliver benefits for biotechs, trial sites and medics, by enabling new medicines to reach patients faster.

Find out more about AdaptiM3D

Cost and time savings in clinical supply

  • Outline drawing of a stopwatch with motion lines, showing the time as approximately 10 seconds.

    Saving 2-3 months on the critical path for clinical trial supply by replacing multiple processes with one operation

    Find out more
  • An illustration of a calendar with a check mark icon, indicating a scheduled or completed appointment or event.

    Reducing manufacturing costs for clinical trial supply by 30-50% - by simplifying the manufacturing process

    Find out more
  • A calendar with a clock in front of it, indicating a scheduled date and time.

    Enabling rapid re-supply after a dose change, reducing total clinical trial elapsed times by eliminating by 2-3 months

    Find out more

Advanced 3D printing technology

AdaptiM3D utilises an advanced 3D printing technology specifically designed for pharmaceutical applications. Our system allows for precise dosing and rapid formulation adjustments without the need for traditional multi-step manufacturing.

Find out more about Core Technology Features

Our Supporters